机译:PD-1封闭性Cemimlimab在先进的皮肤鳞状细胞癌中
Univ Texas MD Anderson Canc Ctr Dept Dermatol 1400 Pressler St 1452 Houston TX 73030 USA;
Peter MacCallum Canc Ctr Dept Med Oncol Melbourne Vic Australia;
Brigham &
Womens Hosp Dept Dermatol 75 Francis St Boston MA 02115 USA;
Royal North Shore Hosp Dept Med Oncol St Leonards Vic Australia;
Schleswig Holstein Univ Hosp Kiel Germany;
Univ Colorado Denver Sch Med Aurora CO USA;
H Lee Moffitt Canc Ctr &
Res Inst Dept Head &
Neck Endocrine Oncol Tampa FL USA;
Washington Univ Sch Med Div Med Oncol Dept Med St Louis MO 63130 USA;
Sir Charles Gairdner Hosp Dept Med Oncol Perth WA Australia;
Stanford Univ Sch Med Dept Dermatol Redwood City CA USA;
Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;
Peter MacCallum Canc Ctr Dept Med Oncol Melbourne Vic Australia;
Mem Sloan Kettering Canc Ctr Dept Med Head &
Neck Med Oncol 1275 York Ave New York NY 10021 USA;
Royal Brisbane &
Womens Hosp Brisbane Qld Australia;
H Lee Moffitt Canc Ctr &
Res Inst Dept Cutaneous Oncol Tampa FL USA;
City Hope Natl Med Ctr Div Dermatol Duarte CA USA;
Univ Hosp Essen Essen Germany;
Regeneron Pharmaceut Basking Ridge NJ USA;
Regeneron Pharmaceut Tarrytown NY USA;
Regeneron Pharmaceut Basking Ridge NJ USA;
Regeneron Pharmaceut Basking Ridge NJ USA;
Regeneron Pharmaceut Tarrytown NY USA;
Regeneron Pharmaceut Basking Ridge NJ USA;
Regeneron Pharmaceut Tarrytown NY USA;
Regeneron Pharmaceut Basking Ridge NJ USA;
Univ Arizona Ctr Canc Tucson AZ USA;
Vall DHebron Univ Hosp Med Oncol Dept Barcelona Spain;
Inst Catala Oncol Barcelona Spain;
Banner MD Anderson Canc Ctr Banner MD Anderson Canc Gilbert AZ USA;
Sarah Cannon Res Inst Nashville TN USA;
Hosp Fdn Jimenez Diaz START Madrid FJD Madrid Spain;
Banner MD Anderson Canc Ctr Dept Med Oncol Gilbert AZ USA;
Emory Univ Dept Hematol &
Med Oncol Winship Canc Inst Atlanta GA 30322 USA;
START San Antonio TX USA;
Regeneron Pharmaceut Tarrytown NY USA;
Regeneron Pharmaceut Tarrytown NY USA;
Regeneron Pharmaceut Tarrytown NY USA;
机译:PD-1封闭性Cemimlimab在先进的皮肤鳞状细胞癌中
机译:意大利先进皮肤鳞状细胞癌患者Cemimpab的初步成本效益及成本实用性分析
机译:Cemimlimab在局部先进的皮肤鳞状细胞癌:开放标签,第2阶段,单臂试验结果
机译:用于皮肤鳞状细胞癌坏死组织区域特征的无标记红外光谱成像
机译:T细胞功能和PD-1检查点延迟肿瘤进展
机译:Cemiznab用于局部晚期和转移皮肤鳞状细胞癌:法国Carepi研究组的现实生活经验
机译:PD-1封闭性Cemimlimab在先进的皮肤鳞状细胞癌中